Clinical trial
Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic…
NCT00449670 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00449670 |
|---|---|
| Title | Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults |
| Official title | Assess the Consistency of the Immunogenicity of a GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults Aged Between 18 and 60 Years |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza, Influenza Vaccines |
| Intervention type | Biological |
| Interventions | H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain), H5N1 non-adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain), H5N1 adjuvanted split virus vaccine (A/Indonesia/05/2005 strain) |
| Enrollment | 1,206 |
| Start date | Mar 24, 2007 |
| Primary completion | Jul 12, 2007 |
| Completion | Jun 10, 2008 |
| First posted | Mar 20, 2007 |
| Last update posted | Apr 9, 2020 |
| Countries | Hong Kong, Singapore, Taiwan, Thailand |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: